-
2021’s Healthiest & Unhealthiest Cities in America – WalletHub Study
Post on 2/8/21
-
SmartBreast Acquires Molecular Breast Imaging Assets from GE Healthcare
Post on 2/8/21
-
Gemini Therapeutics Debuts as Publicly Traded Precision Medicine Company Focused on Age-Related Macular Degeneration
Post on 2/8/21
-
Moderna Short Interest Is Rising. Here's Why I'm Not Worried
Post on 2/8/21
-
Ambu Expands Single-Use Endoscopy Contracts with Two U.S. Group Purchasing Organizations
Post on 2/6/21
-
Vor Biopharma Prices of IPO
Post on 2/5/21
-
Here's How Novavax's Vaccine Stacks Up Against Moderna's and Pfizer's
Post on 2/5/21
-
How Bristol Myers Squibb's Celgene Buyout Continued to Pay Off in Q4
Post on 2/5/21
-
Rhythm Pharmaceuticals Prices of Public Offering
Post on 2/4/21
-
Northern Westchester Hospital Opens State-of-the-art Electrophysiology Lab
Post on 2/4/21
-
EyePoint Pharmaceuticals Closes of $115 Million Public Offering of Common Stock
Post on 2/4/21
-
Alexion Reports Fourth Quarter and Full Year 2020 Results
Post on 2/4/21
-
Biogen Cash Tender Offer for 5.200% Senior Notes
Post on 2/4/21
-
Biogen Announces Private Exchange Offer for 5.200% Senior Notes
Post on 2/4/21
-
Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update
Post on 2/4/21
-
Why Biogen's Q4 Results Were a Bust
Post on 2/4/21
-
Rhythm Pharmaceuticals Proposed Public Offering
Post on 2/4/21
-
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Post on 2/4/21
-
Kaleido Biosciences Proposes Public Offering of Common Stock
Post on 2/4/21
-
Sensei Biotherapeutics Prices of Upsized IPO
Post on 2/4/21
-
Sensei Biotherapeutics Announces Pricing of Upsized IPO
Post on 2/3/21
-
Kaleido Biosciences Prices Public Offering of Common Stock
Post on 2/3/21
-
Reverie Labs Raises $25M Series A Round
Post on 2/3/21
-
Boston Scientific Announces Results For Fourth Quarter And Full Year 2020
Post on 2/3/21
-
Yield10 Bioscience Closes of $12.7 Million Public Offering
Post on 2/3/21
Boston
